Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

Form 8.5 (EPT/RI)

25 Nov 2022 09:00

RNS Number : 6421H
Liberum Capital Limited
25 November 2022
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Liberum Capital Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Science in Sport plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Science in Sport plc

(d) Date dealing undertaken:

24th November 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 10p

 

 

Purchase

 

50,000

 

 

0.1325

 

0.1325

 

ORD 10p

 

 

Sale

 

13,000

 

0.14

 

0.14

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

25th November 2022

 

Contact name:

Kathryn Saunders

Telephone number:

020 3100 2048

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGIBDBCUDDGDU
Date   Source Headline
8th May 202510:34 amRNSForm 8.5 (EPT/RI)
7th May 20253:04 pmRNSForm 8.3 - SCIENCE IN SPORT PLC
6th May 20257:00 amRNSPublication of Scheme Document
2nd May 20254:11 pmRNSDisclosure under Rule 2.10 of the Takeover Code
2nd May 20252:31 pmRNSForm 8.3 - Science in Sport PLC
2nd May 20259:07 amRNSForm 8 (OPD) Science in sport plc
1st May 202510:40 amRNSForm 8.5 (EPT/RI) - Science in Sport PLC
30th Apr 202511:09 amRNSForm 8.3 - Science in Sport PLC
30th Apr 20259:59 amBUSForm 8.3 - Science in Sport PLC
30th Apr 20258:53 amGNWForm 8.5 (EPT/RI) - Science in Sport plc
30th Apr 20258:11 amRNS2024 Annual Report
29th Apr 20259:38 amBUSForm 8.3 - Science in Sport PLC
28th Apr 20257:00 amRNSFinal Results
25th Apr 202512:04 pmRNSForm 8.3 - Science in Sport plc
25th Apr 20259:38 amBUSForm 8.3 - Science in Sport plc
24th Apr 20255:01 pmRNSForm 8.3 - Science in Sport plc
24th Apr 20259:45 amBUSForm 8.3 - Science in Sport PLC
24th Apr 20259:37 amPRNForm 8.3 - Science In Sport Plc
23rd Apr 20255:08 pmBUSForm 8.3 - Science in Sport Plc
23rd Apr 20255:00 pmRNSForm 8.3 – Science in Sport plc
23rd Apr 202511:11 amRNSForm 8.5 (EPT/RI)
22nd Apr 20251:46 pmRNSForm 8.3 - Science in Sport PLC
22nd Apr 20251:44 pmRNSTR-1: Notification of Major Holdings
22nd Apr 202511:58 amRNSForm 8.3 - Science in Sport PLC
22nd Apr 202510:59 amRNSForm 8.5 (EPT/RI)
22nd Apr 20258:12 amGNWForm 8.5 (EPT/RI)-Science in Sport plc
17th Apr 20253:06 pmRNSForm 8.3 - Science in Sport
17th Apr 20252:52 pmGNWForm 8.3 - [SCIENCE IN SPORT PLC - Opening Disclosure - 16 04 2025] - (CGAML)
17th Apr 20252:46 pmRNSForm 8.3 - Science in Sport PLC
17th Apr 20252:39 pmRNSRecommended Cash Acquisition
17th Apr 20252:01 pmRNSForm 8.3 - Science in Sport plc
17th Apr 202512:50 pmRNSForm 8.3 - Science in Sport Plc
17th Apr 202511:46 amRNSForm 8.3 - Science in Sport plc
17th Apr 202510:25 amRNSForm 8.5 (EPT/RI) - Replacement
17th Apr 202510:08 amRNSForm 8.3 - Science in Sport plc
17th Apr 202510:05 amRNSForm 8.5 (EPT/RI)- Science in Sport plc
17th Apr 20259:04 amGNWForm 8.5 (EPT/RI) - Science in Sport plc
16th Apr 20252:36 pmRNSPossible Offer Clarification
16th Apr 20251:49 pmRNSPossible Offer
30th Jan 20257:00 amRNSTrading Statement
21st Nov 20245:32 pmRNSNotification of major holdings
27th Sep 20247:00 amRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSNotification of Major Holdings
18th Sep 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSInterim Results
15th Aug 20248:48 amRNSReplacement: Result of Annual General Meeting
31st Jul 20245:03 pmRNSResult of Annual General Meeting
31st Jul 20244:01 pmRNSNotification of Major Holdings
31st Jul 20244:00 pmRNSReplacement: Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.